Genmab
GMAB
$39.57
Share price
0.61%
Change (1 day)
30.55%
Change (1 year)
Categories
Revenue for Genmab (GMAB)
Revenue in 2023 (TTM): $2.15 B
According to Genmab's latest financial reports the company's current revenue (TTM) is $2.15 B. In 2022 the company made a revenue of $2.05 B an increase over the years 2021 revenue that were of $1.32 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Genmab from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $2.15 B | 4.86% |
| 2022 | $2.05 B | 55.21% |
| 2021 | $1.32 B | -15.36% |
| 2020 | $1.56 B | 94.78% |
| 2019 | $0.80 B | 69.1% |
| 2018 | $0.47 B | 28.2% |
| 2017 | $0.37 B | 39.77% |
| 2016 | $0.26 B | 57.99% |
| 2015 | $0.16 B | 13.12% |
| 2014 | $0.14 B | 25% |
| 2013 | $0.11 B | 40.03% |
| 2012 | $84.71 M | 30.65% |
| 2011 | $64.84 M | -36.88% |
| 2010 | $0.10 B | -5.92% |
| 2009 | $0.10 B |